Authors
Department of Otorhinolaryngology, Kashani Hospital, Isfahan University of Medical Sciences, Isfahan, Iran
Abstract
Background: This study was done to evaluate the effect of itraconazole on clinical symptoms and radiologic findings in patients with chronic rhinosinusitis and nasal polyposis after surgery.
Materials and Methods: In a clinical trial which was conducted in Alzahra and Kashani hospitals, from November 2011 to December 2012, 22 patients with recurrent postsurgical chronic sinusitis and polyposis entered the study. At the start of the study demographic data, subjective clinical symptoms (severity of rhinorrhea, nasal obstruction, hyposmia, and dyspnea), quality of life (QoL) by sinonasal outcome test-20 (SNOT-20), serum immunoglobulin E (IgE), and score of computed tomography (CT) scan (by Lund-Mackay) were recorded. Itraconazole (100 mg, twice per day) prescribed for 3 months and patients were followed in the 1 st , 3 rd , and 6 th months. Liver enzyme tests and side effects were evaluated monthly.
Results: Severity of rhinorrhea, nasal obstruction, hyposmia, dyspnea, and QoL (by SNOT-20) improved during 3 months of treatment. Serum IgE was 265 (±277) at the start of the study, and decrease to 193 (±183) after 3 month. After 3 month, Lund-Mackay score of CT scan lowered from 19 (±4) to 15 (±6) (P < 0.05). At the 6 th month, severity of clinical symptoms except dyspnea and QoL were better than first evaluation.
Conclusion: This study showed the beneficial effect of 3-month itraconazole treatment on clinical symptoms and radiologic findings and QoL in patients with recurrent postsurgical chronic rhinosinusitis and nasal polyposis.
Keywords
1. | Benninger MS. The pathogenesis of rhinosinusitis In: Flint PW, Haughey BH, Lund VJ, Niparko J, Richardson MA, Robbins KT, Thomas JR, editors. Cummings Otolaryngology: Head and Neck Surgery. 5 th ed., vol 47. Maryland Heights: Mosby, Elsevier; 2010. p. 705-7. |
2. | Lanza DC, Kennedy DW. Adult rhinosinusitis defined. Otolaryngol Head Neck Surg 1997;117:S1-7. |
3. | Benninger MS, Ferguson BJ, Hadley JA, Hamilos DL, Jacobs M, Kennedy DW, et al. Adult chronic rhinosinusitis: Definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg 2003;129:S1-32. |
4. | Khalid AN, Quraishi SA, Kennedy DW. Long-term quality of life measures after functional endoscopic sinus surgery. Am J Rhinol 2004;18:131-6. |
5. | Ray NF, Baraniuk JN, Thamer M, Rinehart CS, Gergen PJ, Kaliner M, et al. Healthcare expenditures for sinusitis in 1996: Contributions of asthma, rhinitis, and other airway disorders. J Allergy Clin Immunol 1999;103:408-14. |
6. | Jain S, Das S, Gupta N, Malik JN. Frequency of fungal isolation and antifungal susceptibility pattern of the fungal isolates from nasal polyps of chronic rhinosinusitis patients at a tertiary care centre in north India. Med Mycol 2013;51:164-9. |
7. | Ponikau JU, Sherris DA, Kern EB, Homburger HA, Frigas E, Gaffey TA, et al. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc 1999;74:877-84. |
8. | Braun H, Buzina W, Freudenschuss K, Beham A, Stammberger H. 'Eosinophilic fungal rhinosinusitis': A common disorder in Europe? Laryngoscope 2003;113:264-9. |
9. | Taylor MJ, Ponikau JU, Sherris DA, Kern EB, Gaffey TA, Kephart G, et al. Detection of fungal organisms in eosinophilic mucin using a fluorescein-labeled chitin-specific binding protein. Otolaryngol Head Neck Surg 2002;127:377-83. |
10. | Kennedy DW, Kuhn FA, Hamilos DL, Zinreich SJ, Butler D, Warsi G, et al. Treatment of chronic rhinosinusitis with high-dose oral terbinafine: A double blind, placebo-controlled study. Laryngoscope 2005;115:1793-9. |
11. | Hamilos DL, Lund VJ. Etiology of chronic rhinosinusitis: The role of fungus. Ann Otol Rhinol Laryngol Suppl 2004;193:27-31. |
12. | Pant H, Kette FE, Smith WB, Wormald PJ, Macardle PJ. Fungal-specific humoral response in eosinophilic mucus chronic rhinosinusitis. Laryngoscope 2005;115:601-6. |
13. | Chan KO, Genoway KA, Javer AR. Effectiveness of itraconazole in the management of refractory allergic fungal rhinosinusitis. J Otolaryngol Head Neck Surg 2008;37:870-4. |
14. | Bachert C, Gevaert P, van Cauwenberge PA. Middleton's allergy: Principles and practice. In: Adamko DJ, Adkinson NF Jr, Akdis CA, Amrani Y, Apter AJ, Avila-Tang E, editors. Nasal Polyps and Rhinosinusitis. 7 th ed. Philadelphia: Mosby; 2008. p. 56-991. |
15. | Ricchetti A, Landis BN, Giger R, Zheng C, Lacroix JS. Effect of local antifungal treatment on nasal polyposis. Otorhinoloaryngologia 2002/2003;12:48-51. |
16. | Hashemi SM, Mokhtarinejad F, Karim M, Okhovat SH. Does amphotericin B nasal douching help prevent polyp recurrence following functional endoscopic sinus surgery? J Res Med Sci 2011;16:74-8. [PUBMED] |
17. | Yagi HI, Gumaa SA, Shumo AI, Abdalla N, Gadir AA. Nasosinus aspergillosis in Sudanese patients: Clinical features, pathology, diagnosis, and treatment. J Otolaryngol 1999;28:90-4. |
18. | Grant SM, Clissold SP. Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses. Drugs 1989;37:310-44. |
19. | Mohr J, Johnson M, Cooper T, Lewis JS, Ostrosky-Zeichner L. Current options in antifungal pharmacotherapy. Pharmacotherapy 2008;28:614-45. |
20. | Piccirillo JF, Merritt MG Jr, Richards ML. Psychometric and clinimetric validity of the 20-Item Sino-Nasal Outcome Test (SNOT-20). Otolaryngol Head Neck Surg 2002;126:41-7. |
21. | Ali SN, Zangi M, Naeini PS, Haj Fathali AR. Evaluating diagnostic value of clinical symptoms and signs for sinusitis by CT scan at Milad hospital. JAUMS 2007;5:1245-49. |
22. | Rains BM 3 rd , Mineck CW. Treatment of allergic fungal sinusitis with high-dose itraconazole. Am J Rhinol 2003;17:1-8. |
23. | Seiberling K, Wormald PJ. The role of itraconazole in recalcitrant fungal sinusitis. Am J Rhinol Allergy 2009;23:303-6. |
24. | Lal D, Stankiewicz JA. Antifungal treatment and chronic rhinosinusitis. Curr Allergy Asthma Rep 2009;9:227-31. |
25. | Stevens DA, Schwartz HJ, Lee JY, Moskovitz BL, Jerome DC, Catanzaro A, et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 2000;342:756-62 |